It’s is about time clinical trials change their traditional focus from observing large groups of largely undifferentiated patients to the individual patient as the unit of observation.

Norman Goldfarb, Editor of the First Clinical Research Journal talks with Chris Beardmore, CEO & Co-founder of Anova Enterprises about the concept of N=1 clinical trials.  To access the interview in full, click here.